Work

Vadastuximab Talirine Monotherapy in Older Patients with Treatment Naive CD33-Positive Acute Myeloid Leukemia (AML)

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.590.590

Authors: Dale L. Bixby, Anthony S. Stein, Amir T. Fathi, Tibor J. Kovacsovics, Moshe Y Levy, Harry P. Erba, Jeffrey E. Lancet, Anand P Jillella, Farhad Ravandi, Roland B. Walter, Eytan M. Stein, Stefan Faderl, Daniel J. DeAngelo, Phoenix Ho, Megan M. O'Meara, Jenna L Voellinger, Anjali Advani

Institutions: University of Michigan, Michigan Medicine, City Of Hope National Medical Center, City of Hope, Massachusetts General Hospital, University of Utah, Huntsman Cancer Institute, Baylor University Medical Center, University of Alabama at Birmingham, Moffitt Cancer Center, Winship Cancer Institute, Fred Hutch Cancer Center, Memorial Sloan Kettering Cancer Center, Hackensack University Medical Center, Dana-Farber Cancer Institute, Seagen (United States), Cleveland Clinic

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2560829310

FWCI: 5.268

Cites:

Cited by: 29

Related to: 10